-
K288441-5mgPDGFRβ, B-Raf, c-Raf, FLT3 and KIT inhibitor.
-
K292913-1mlKlenow Fragment (3'→5' exo-).
-
K292908-1mlKlenow Fragment.
-
K292908-250μlKlenow Fragment.
-
K292908-50μlKlenow Fragment.
-
K288581-100mgPotent DDHD2 inhibitor.
-
K288581-10mgPotent DDHD2 inhibitor.
-
K288581-250mgPotent DDHD2 inhibitor.
-
K288581-25mgPotent DDHD2 inhibitor.
-
K288581-50mgPotent DDHD2 inhibitor.
-
K288581-5mgPotent DDHD2 inhibitor.
-
K287859-100mgProduct Describtion:KML29 is an extremely selective, orally active and irreversible inhibitor of MAGL with IC50 of 15 nM, 43 nM and 5.9 nM for mouse, rat and human MAGL, respectively.